1,679
Views
30
CrossRef citations to date
0
Altmetric
Original Articles

The value of routine follow-up after treatment for head and neck cancer. A National Survey from DAHANCA

, , , , , , , , , , , & show all
Pages 277-284 | Received 24 Aug 2012, Accepted 03 Oct 2012, Published online: 16 Jan 2013

References

  • de Visscher AV, Manni JJ. Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity. Does it make sense? Arch Otolaryngol Head Neck Surg 1994; 120:934–9.
  • Digonnet A, Hamoir M, Andry G, Haigentz M, Jr., Takes RP, Silver CE, . Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol Epub 2012 Sep 13.
  • Overgaard J, Hansen HS, Specht L, Overgaard M, Grau C, Andersen E, . Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 2003;362:933–40.
  • Grau C, Specht LK, Hansen HS, Overgaard M, Overgaard J. [Centralized follow-up of patients treated for head and neck cancer]. Ugeskr Laeger 1997;159:1104–8.
  • Kothari P, Trinidade A, Hewitt RJ, Singh A, O’Flynn P. The follow-up of patients with head and neck cancer: An analysis of 1,039 patients. Eur Arch Otorhinolaryngol 2011;268:1191–200.
  • Agrawal A, deSilva BW, Buckley BM, Schuller DE. Role of the physician versus the patient in the detection of recurrent disease following treatment for head and neck cancer. Laryngoscope 2004;114:232–5.
  • Schwartz DL, Barker J, Jr., Chansky K, Yueh B, Raminfar L, Drago P, . Postradiotherapy surveillance practice for head and neck squamous cell carcinoma – too much for too little?Head Neck 2003;25:990–9.
  • Ataman OU, Barrett A, Davidson S, De Haas-Kock D, Dische S, Dubray B, . Audit of effectiveness of routine follow-up clinics after radiotherapy for cancer: A report of the REACT working group of ESTRO. Radiother Oncol 2004;73:237–49.
  • Overgaard J, Hansen HS, Jorgensen K, Hjelm HM. Primary radiotherapy of larynx and pharynx carcinoma – an analysis of some factors influencing local control and survival. Int J Radiat Oncol Biol Phys 1986;12:515–21.
  • Boysen M, Lovdal O, Tausjo J, Winther F. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer 1992;28:426–30.
  • Lester SE, Wight RG. ‘When will I see you again?‘ Using local recurrence data to develop a regimen for routine surveillance in post-treatment head and neck cancer patients. Clin Otolaryngol 2009;34:546–51.
  • Jensen K, Lambertsen K, Grau C. Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: Frequency, intensity and correlation with dose and volume parameters. Radiother Oncol 2007;85:74–82.
  • Mortensen HR, Overgaard J, Specht L, Overgaard M, Johansen J, Evensen JF, . Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6 & 7 randomised trial with accelerated radiotherapy for head and neck cancer.Radiother Oncol 2012;103:69–75.
  • Haas I, Hauser U, Ganzer U. The dilemma of follow-up in head and neck cancer patients. Eur Arch Otorhinolaryngol 2001;258:177–83.
  • Bjordal K, Kaasa S. Psychological distress in head and neck cancer patients 7–11 years after curative treatment. Br J Cancer 1995;71:592–7.
  • Rennemo E, Zatterstrom U, Boysen M. Impact of second primary tumors on survival in head and neck cancer: An analysis of 2,063 cases. Laryngoscope 2008;118:1350–6.
  • Johansen LV, Overgaard J, Hjelm-Hansen M, Gadeberg CC. Primary radiotherapy of T1 squamous cell carcinoma of the larynx: Analysis of 478 patients treated from 1963 to1985. Int J Radiat Oncol Biol Phys1990;18:1307–13.
  • Flynn CJ, Khaouam N, Gardner S, Higgins K, Enepekides D, Balogh J, . The value of periodic follow-up in the detection of recurrences after radical treatment in locally advanced head and neck cancer. Clin Oncol (R Coll Radiol) 2010;22:868–73.
  • O’Meara WP, Thiringer JK, Johnstone PA. Follow-up of head and neck cancer patients post-radiotherapy. Radiother Oncol 2003;66:323–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.